Annual Debt To Equity
-0.62
-0.63-6300.00%
December 31, 2023
Summary
- As of February 25, 2025, QLGN annual debt to equity ratio is -0.62, with the most recent change of -0.63 (-6300.00%) on December 31, 2023.
- During the last 3 years, QLGN annual debt to equity has fallen by -0.63 (-6300.00%).
- QLGN annual debt to equity is now -6300.00% below its all-time high of 0.01, reached on December 1, 2020.
Performance
QLGN Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.67
-0.28-71.79%
September 30, 2024
Summary
- As of February 25, 2025, QLGN quarterly debt to equity ratio is -0.67, with the most recent change of -0.28 (-71.79%) on September 30, 2024.
- Over the past year, QLGN quarterly debt to equity has stayed the same.
- QLGN quarterly debt to equity is now -142.68% below its all-time high of 1.57, reached on June 30, 2023.
Performance
QLGN Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
QLGN Debt To Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6300.0% | 0.0% |
3 y3 years | -6300.0% | 0.0% |
5 y5 years | +46.1% | 0.0% |
QLGN Debt To Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -6300.0% | at low | -142.7% | at low |
5 y | 5-year | -6300.0% | +46.1% | -142.7% | at low |
alltime | all time | -6300.0% | +46.1% | -142.7% | at low |
Qualigen Therapeutics Debt To Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -0.67(+71.8%) |
Jun 2024 | - | -0.39(+34.5%) |
Mar 2024 | - | -0.29(-53.2%) |
Dec 2023 | -0.62(-6300.0%) | -0.62(+21.6%) |
Sep 2023 | - | -0.51(-132.5%) |
Jun 2023 | - | 1.57(+153.2%) |
Mar 2023 | - | 0.62(+6100.0%) |
Dec 2022 | 0.01 | 0.01(-95.2%) |
Sep 2022 | - | 0.21(+250.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | 0.06(>+9900.0%) |
Mar 2022 | - | 0.00(0.0%) |
Dec 2021 | 0.00(-100.0%) | 0.00(0.0%) |
Sep 2021 | - | 0.00(0.0%) |
Jun 2021 | - | 0.00(0.0%) |
Mar 2021 | - | 0.00(-100.0%) |
Dec 2020 | 0.01(-100.9%) | - |
Sep 2020 | - | -0.33(+230.0%) |
Jun 2020 | - | -0.10 |
Mar 2020 | -1.15 | - |
FAQ
- What is Qualigen Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual debt to equity year-on-year change?
- What is Qualigen Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly debt to equity year-on-year change?
What is Qualigen Therapeutics annual debt to equity ratio?
The current annual debt to equity of QLGN is -0.62
What is the all time high annual debt to equity for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual debt to equity ratio is 0.01
What is Qualigen Therapeutics annual debt to equity year-on-year change?
Over the past year, QLGN annual debt to equity ratio has changed by -0.63 (-6300.00%)
What is Qualigen Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of QLGN is -0.67
What is the all time high quarterly debt to equity for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly debt to equity ratio is 1.57
What is Qualigen Therapeutics quarterly debt to equity year-on-year change?
Over the past year, QLGN quarterly debt to equity ratio has changed by 0.00 (0.00%)